Project description
The making of a multinational, adaptive European COVID-19 trial network
The emergence of the COVID-19 pandemic has demonstrated the necessity of improving the global clinical trial capacity based on the cooperation between the EU and international partners. DisCoVeRy (WP1), designed as a multi-arm adaptive repurposing trial, can be expanded to several European countries with adequate multinational financing and trial management capacity. The EU-funded EU-RESPONSE project will establish a multinational, adaptive European COVID-19 and emerging infectious diseases trial network, taking advantage of the existing initiatives, allowing the European expansion of DisCoVeRy (WP1) and the creation of a COVID-19 adaptive platform trial (WP2). The project will produce solid evidence for drug repurposing or registration, permitting most European hospitals to participate at their preferred level of commitment in establishing a network of investigation sites within the EU and associated countries.
Programme(s)
Call for proposal
H2020-IBA-SC1-CORONAVIRUS-2020-3
See other projects for this call
Funding Scheme
RIA - Research and Innovation actionCoordinator
75654 Paris
France
Participants (20)
75013 Paris
0456 Oslo
0450 Oslo
37129 Verona
4200 319 Porto
75013 Paris
04180 Kosice
1050 Bruxelles
6720 Szeged
T12 YN60 Cork
3008 Bern
06800 Cankaya Ankara
1210 Luxembourg
1180 Wien
75000 Paris
69002 Lyon
28020 Madrid
10561 Athina
90419 Lodz
116 36 Praha 1